New & Noteworthy

Submit New & Noteworthy

December 2020

Nizatidine Oral Solution

Amneal Pharmaceuticals

Amneal Pharmaceuticals announces its nizatidine oral solution 15 mg/mL (75 mg/5 mL), a generic equivalent of Axid, available for reorder. Meeting all FDA requirements and specification limits related to NDMA, the solution is used for the short-term treatment and maintenance therapy of ulcers and the treatment of esophagitis and heartburn due to gastroesophageal reflux disease (GERD). The solution is available as a peppermint-flavored liquid in 480 mL bottles.

Amneal Pharmaceuticals

Click here to view product detail on Findit.

Current Issue